Midgard Science
TaiMed Biologics

TaiMed Biologics

Taipei, Taiwan taimedbiologics.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

TaiMed Biologics is a commercial-stage biologics company in Taiwan that develops antibody-based therapies for HIV and other immune-related areas. It also provides CDMO services for monoclonal antibody and biologics programs from development through cGMP manufacturing. Its headquarters are in Taipei City, with a branch office in Zhubei City, Hsinchu County.

TaiMed Biologics is a CRDMO in Taipei, Taiwan, founded in 2007. It lists 6 services, including CD4-ADC Platform, Process Development and Formulation Development. It names GMP on its listing.

Services

  • CD4-ADC Platform

    Explores TMB-365 as a targeting vehicle for antibody-drug conjugates to deliver payloads to CD4+ cells in preclinical research.

  • Process Development

    Provides upstream and downstream process development and optimization to support scalable biologics manufacturing.

  • Formulation Development

    Provides formulation and stability development to support product performance, storage, and clinical or commercial requirements.

  • Analytical Development

    Provides analytical method development, qualification/validation, product characterization, and stability testing.

  • cGMP Manufacturing

    Provides single-use manufacturing capabilities supporting clinical and commercial biologics production.

  • Regulatory Support

    Provides CMC and regulatory support informed by its own biologics development and commercialization experience.

How to order from TaiMed Biologics

They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Antibodies
  • ADCs
  • Analytical development
  • Process development
  • Stability studies
  • Analytical method development
8 more
  • Qualification
  • Validation
  • Product characterization
  • Stability testing
  • Binding studies
  • Internalization studies
  • Payload release studies
  • In vitro antiviral activity
Scale and capacity
  • Approximately 60,000 square feet supporting cGMP operations
  • Pilot scale to full commercialization
Therapeutic areas
  • HIV
  • Infectious disease
  • Autoimmune disease
  • Immune-mediated diseases

Modalities and species

Modalities
  • Antibody
  • ADC
Species and models
  • CD4+ cells
  • Long-lived CD4+ T cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

Details

Type
CRDMO
Founded
2007
Based in
Taipei, Taiwan
Sites
  • Taipei City, Taiwan
  • Zhubei City, Hsinchu County, Taiwan
Serves
Multiple countries worldwide

Similar labs